Table 2.

Factors associated with time to diagnostic resolution (T1) following breast cancer screening abnormality in the Chicago Cancer Navigation Project

T1 in days60 days
CharacteristicsaHRa,b (95%CI)aORb (95%CI)
 Patient navigation
 Control sitesRefcRef
 Navigated Sites1.65** (1.20–2.28)1.88 (0.75–4.70)
Race/ethnicityd
 BlackRefRef
 Hispanic1.43 (0.97–2.10)1.52 (0.63–3.67)
Age0.98** (0.97–0.99)0.96* (0.92–0.99)
Insurance status
 PrivateRefRef
 Uninsured1.04 (0.68–1.60)1.34 (0.56–3.21)
 Public1.16 (0.73–1.84)0.87 (0.33–2.28)
Marital status
 Current partneredRefRef
 Never partnered0.67** (0.50–0.91)0.54 (0.26–1.12)
 Past partnered0.82 (0.57–1.18)0.85 (0.34–2.13)
Eligibility
 Clinical Breast ExamRefRef
 Mammogram/ultrasound0.55** (0.40–0.78)0.47 (0.18–1.25)
Mammogram/ultrasound findings
 All other womenRefRef
 BI-RADS 30.37** (0.23–0.61)0.08** (0.02–0.26)

*, P < 0.05 and **, P < 0.01.

  • aHigher HR corresponds to shorter time interval.

  • bAnalyses adjusted for all variables listed in the table and site random effects.

  • cRef, reference group.

  • dWhites and Others only comprised 2% of cases in the sample and dropping them from the analyses did not change the results.